Shattuck Labs, Inc. (STTK) - Form 8-K Summary
Business Context and Reporting Period
Shattuck Labs, Inc., a Delaware corporation, filed this Current Report on Form 8-K on May 7, 2026. The filing announces the issuance of a press release detailing financial results for the quarter ended March 31, 2026. The company's common stock trades on The Nasdaq Global Select Market under the symbol STTK.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification of the results announcement and incorporates the detailed financial data by reference to Exhibit 99.1 (the press release), which is not included in the provided text.
Material Changes
No material changes versus the prior comparable period are described in the provided text. The document only confirms the timing of the results announcement.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These details are contained within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue, net loss, and cash position figures.
- Verify the company's cash runway and burn rate as disclosed in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the full announcement.
- Confirm if the company provided updated full-year 2026 financial guidance in the press release.